1. American Association of Clinical Endocrinologists: Comprehensive Type 2 Diabetes Management Algorithm (2020) — Executive Summary.
  2. Solomon, SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:412–418.
  3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease.
  4. American Diabetes Association. Standards of Medical Care in Diabetes 2020. Diabetes Care. 2020; 43 (Supplement 1).
  5. Center for Disease Control and Prevention. Chronic disease prevention and health promotion.
  6. Segal AR, et al. Insulin: making sense of current options. Endocrinol Metab Clin North Am. 2016;45(4):845–874.
  7. Roth EG, et al. Diabetes and the motivated patient: understanding perlocutionary effect in health communication. Health Commun. 2017;32(4):502-508.
  8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
  9. Baptista DR, et al. The chronic care model for type 2 diabetes: a systematic review. Diabetol Metab Syndr. 2016;8:7.
  10. Hewston P, Deshpande N. The short version of the activities-specific balance confidence scale for older adults with diabetes-convergent, discriminant and concurrent validity: a pilot study. Can J Diabetes. 2017;41(3):266-272.
  11. American Diabetes Association. Strategies for improving care. Diabetes Care. 2016;39(Supplement 1): S6-S12.
  12. American Association of Clinical Endocrinologists. Diabetes Resource Center.
  13. Micha R, Peñalvo JL, Cudhea F, et al. Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA. 2017;317(9):912-924.
  14. Otto MC, Afshin A, Micha R, et al; Global Burden of Diseases, Injuries, and Risk Factors Metabolic Risk Factors of Chronic Diseases Expert Group; Nutrition and Chronic Diseases Expert Group (NutriCoDE). The impact of dietary and metabolic risk factors on cardiovascular diseases and type 2 diabetes mortality in Brazil. PLoS One. 2016;11(3):e0151503.
  15. Yang CJ, Hsu HY, Lu CH, et al. Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality? J Diabetes Investig. 2018;9(1):179-185.
  16. Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017;8(5):646-655.
  17. Strain WD, Agarwal AS, Paldánius PM. Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. Aging (Albany NY). 2017;9(3):769-777.
  18. Brahimaj A, Ligthart S, Ghanbari M, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217-226.
  19. Hutchison AT, Wittert GA, Heilbronn LK. Matching meals to body clocks-impact on weight and glucose metabolism. Nutrients. 2017;9(3). pii: E222.
  20. Wise J. Complications are more common in young people with type 2 diabetes than type 1. BMJ. 2017 Mar 1;356:j1082.
  21. Kuhn A, Park J, Ghazi A, Aroda VR. Intensifying treatment beyond monotherapy in type 2 diabetes mellitus: where do newer therapies fit? CurrCardiol Rep. 2017;19(3):25.
Font Size